Corrigendum to "Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs" (Pharmacol. Res. 146 (2019) 104269)
1 Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China.
2 Department of Pathology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China.
3 Department of General Practice, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China.
4 Department of Cardiology, The Second Affiliated Hospital of HarbinMedical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China. Electronic address: maomaolp1983@163.com.